Imagen de Portada

Role of nuclear medicine in the treatment of GEP-NETs. The brazilian experience with PRRT: a first line therapeutic option?

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Aron Belfer
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Sociedad Argentina de Gastroenterología 2009
Materias:	Medicina
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Images in GEP-NETs - Diagnosis and Staging
por: Aron J Belfer
Publicado: (2009)

Epidemiology. Brazilian experience: GEP-NETs registry
por: Riad Younes
Publicado: (2009)

Role of surgery in NETs in both primary and metastatic disease
por: Riad Younes
Publicado: (2009)

Síndromes hereditarios en TNE-GEP
por: Patricia Fainstein Day
Publicado: (2009)

Fetal cardiac interventions: an update of therapeutic options
por: Shi-Min Yuan
Publicado: (2014)

Postperfusion lung syndrome: physiopathology and therapeutic options
por: Shi-Min Yuan
Publicado: (2014)

Claves en el diagnóstico histopatológico de los TNE-GEP
por: Enzo Domenichini
Publicado: (2009)

Marcadores biológicos en TNE-GEP: 5HIAA, Cromogranina sérica, Catecolaminas
por: Susana Belli
Publicado: (2009)

Role of nuclear medicine in cardiology
por: Eman Aslam
Publicado: (2026)

II Jornadas de Actualización en Tumores Neuroendócrinos Gastro-Entero-Pancreáticos (TNE-GEP)
por: Fabiana Marmissolle
Publicado: (2009)

Gaza’s Tangentopoli
por: Mitchell A. Belfer
Publicado: (2012)

Iranian Claims to Bahrain: from Rhetoric to Interference
por: Mitchell A. Belfer
Publicado: (2014)

Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study
por: Rinaldo Pellicano
Publicado: (2019)

Quimioterapia clásica y la incorporación de nuevas terapias dirigidas a blancos moleculares en TNE-GEP
por: Guillermo Méndez
Publicado: (2009)

Energy and GHG policy options for Mexico's private transport / Arón Jazcilevich
por: Jazcilevich, Arón

PRRT plus holmium‐166‐SIRT (HEPAR PLuS) versus PRRT‐only in patients with metastatic neuroendocrine tumors: A propensity‐score matched analysis
por: W. B. Veldhuis, et al.
Publicado: (2025)

Cost-effectiveness of nilotinib, dasatinib and imatinib as first-line treatment for chronic myeloid leukemia in Colombia, 2012
por: Martín Romero
Publicado: (2014)

Pharmacogenomics: a perspective of personalized medicine in CHD treatment as a model
por: Aidas Pranculis
Publicado: (2011)

Fecal microbiota transplantation as an early therapeutic option in treatment refractory Clostridioides difficile infection
por: OC Buldukoglu, et al.
Publicado: (2024)

CO 2 laser in the treatment of acral persistent papular mucinosis: an emerging therapeutic option?
por: André Aparício Martins, et al.
Publicado: (2026)

The influence of alternative medicine in highly active antiretroviral treatment
por: M. Vázquez Hernández
Publicado: (2009)

The progress of brazilian neuropsychology. From research to clinical practice
por: Emmy Uehara
Publicado: (2016)

Flawed Benchmarks and Biased Cohorts: Reassessing the Evidence for CP ‐ GEP (Merlin) Versus 31‐ GEP ( DecisionDx ‐Melanoma)
por: Domenico Bellomo, et al.
Publicado: (2025)

Endovascular treatment of endotension with dacron stent graft reinforcement and femorofemoral crossover bypass - therapeutic challenge
por: Edwaldo Edner Joviliano
Publicado: (2010)

New insights into the therapeutic options to lower lipoprotein(a)
por: A. Baragetti, et al.
Publicado: (2024)

Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report
por: Erwing Castillo
Publicado: (2019)

Left subclavian artery stenting: an option for the treatment of the coronary-subclavian steal syndrome
por: Bruno Lorenção de Almeida
Publicado: (2014)

Evaluation of pharmacy students' clinical interventions on a general medicine practice experience
por: Jocelyn D. JONES
Publicado: (2011)

PRRT in high‐grade digestive neuroendocrine neoplasms ( NET G3 and NEC )
por: Halfdan Sorbye, et al.
Publicado: (2024)

Complementary medicine use in cancer patients receiving intravenous antineoplastic treatment
por: Regina Juanbeltz
Publicado: (2017)

Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell lung cancer in Spain
por: Jonathan González García
Publicado: (2017)

COPD: Evidence-based medicine or the patient-centered medicine?
por: A. Araújo
Publicado: (2016)

Abexol: a therapeutic option for the management of symptoms in patients with osteoarthritis
por: Julio César Fernández Travieso
Publicado: (2019)

What are the first-line and alternative treatments for amebiasis?
por: Tripdatabase
Publicado: (2025)

What are the first-line drugs for the treatment of hypertension?
por: Tripdatabase
Publicado: (2025)

Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis
por: Yan Chen
Publicado: (2007)

Ivermectin as a promising therapeutic option for onchocerciasis‐associated epilepsy
por: Mohammad Amin Manavi, et al.
Publicado: (2024)

Study on adherence to treatment with imatinib in chronic myeloid leukaemia and its association with therapeutic response
por: Marta García-Queiruga
Publicado: (2016)

GEP Prediction: Angular Anisotropy of Photon Phase Velocity
por: Sekanina, Štěpán
Publicado: (2026)

Taking a pause: An option rarely considered for students and professionals
por: Juan Camilo Gómez-Ospina
Publicado: (2024)